Historie von Umsatz, Gewinn und Cashflow aus den offiziellen Geschäftsberichten.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Interaktive Charts und vollständige Abschlüsse ansehen → Bewertungsmodell (DCF) →
| Gewinn- und Verlustrechnung | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gesamtumsatz | $21.0B | $20.4B | $20.1B | $19.5B | $18.0B | $17.4B | $16.5B | $15.7B | $15.5B | $15.5B | $15.2B | $16.0B | $17.3B | $17.4B | $17.1B | $16.7B | $15.6B | $15.3B | $15.3B | $13.8B | $12.2B |
| Bruttoergebnis | $12.7B | $12.3B | $12.1B | $11.3B | $10.2B | $10.3B | $9.9B | $9.3B | $9.2B | $9.3B | $9.1B | $9.4B | $10.1B | $10.2B | $9.9B | $9.6B | $9.2B | $9.0B | $8.7B | $7.9B | $6.9B |
| Bruttomarge % | 60.4% | 60.1% | 60.2% | 57.8% | 56.5% | 59.1% | 60.3% | 59.1% | 59.2% | 60.3% | 60.1% | 58.4% | 58.5% | 58.7% | 58.0% | 57.5% | 59.0% | 58.9% | 56.5% | 57.0% | 56.2% |
| Betriebsergebnis (EBIT) | $4.3B | $4.3B | $4.4B | $4.1B | $3.6B | $3.9B | $3.9B | $3.8B | $3.9B | $4.0B | $4.0B | $4.0B | $4.2B | $4.1B | $4.0B | $3.9B | $3.8B | $3.7B | $3.3B | $2.9B | $2.6B |
| Operative Marge % | 20.6% | 21.3% | 21.8% | 21.2% | 20.0% | 22.3% | 23.7% | 24.0% | 24.8% | 25.9% | 26.1% | 24.8% | 24.2% | 23.7% | 23.4% | 23.1% | 24.2% | 24.4% | 21.7% | 21.3% | 21.0% |
| Jahresüberschuss | $2.0B | $2.1B | $2.9B | $2.3B | $1.8B | $2.2B | $2.7B | $2.4B | $2.4B | $2.0B | $2.4B | $1.4B | $2.2B | $2.2B | $2.5B | $2.4B | $2.2B | $2.3B | $2.0B | $1.7B | $1.4B |
| Nettomarge % | 9.7% | 10.5% | 14.4% | 11.8% | 9.9% | 12.4% | 16.4% | 15.1% | 15.4% | 13.1% | 16.1% | 8.6% | 12.6% | 12.9% | 14.5% | 14.5% | 14.1% | 14.9% | 12.8% | 12.6% | 11.1% |
| EBITDA | — | $4.0B | $4.9B | $4.2B | $3.4B | $3.8B | $4.3B | $4.0B | $4.2B | $4.1B | $4.3B | $3.3B | $4.1B | $4.1B | $4.4B | $4.3B | $3.9B | $4.0B | $3.5B | $3.1B | $2.6B |
| Ergebnis je Aktie (EPS) | $2.52 | $2.63 | $3.51 | $2.77 | $2.13 | $2.55 | $3.14 | $2.75 | $2.75 | $2.28 | $2.72 | $1.52 | $2.36 | $2.38 | $2.57 | $2.47 | $2.16 | $2.18 | $1.83 | $1.63 | $1.26 |
| Ausstehende Aktien (Mio.) | — | 811M | 822M | 829M | 839M | 848M | 859M | 861M | 873M | 888M | 898M | 910M | 924M | 940M | 960M | 984M | 1,022M | 1,049M | 1,070M | 1,068M | 1,077M |
Quelle: veröffentlichte Unternehmensberichte (SEC). Bitte prüfen Sie die Zahlen vor Verwendung auf SEC EDGAR.
Bilanzen, Cashflow-Rechnungen, Quartalsdaten und alle Kennzahlen finden Sie im interaktiven Viewer für CL. /companies/us/CL
Die Informationen auf dieser Website dienen ausschließlich Bildungs- und Informationszwecken und stellen keine Anlageberatung dar. Es werden keine Kursziele und keine Anlageurteile veröffentlicht.
About TickerBase · Data methodology & sources · Privacy · Terms